Recruiting
Phase 3

RSV Vaccine in Transplant Recipients

Sponsor:

University Health Network, Toronto

Code:

NCT06593210

Conditions

Vaccine Response Impaired

Respiratory Syncytial Virus Infections

Immune Suppression

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Adjuvant, non-live RSV vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information